Statin pills much safer than advertised, major review finds

In a significant shift towards prioritizing prevention in healthcare, a slew of medical breakthroughs is poised to revolutionize the way we tackle some of the world's most pressing health concerns. From the revelation that statins are safer than previously thought to innovative cancer screening methods and a renewed focus on preventing female genital mutilation (FGM), cancer, and cholera, these advances are set to save countless lives and improve the health of millions worldwide. Firstly, a major review published in The Lancet journal has found that statins, cholesterol-lowering drugs taken by millions, are far safer than previously thought. The study, which involved over 120,000 people, revealed that statins do not cause the majority of possible side effects listed, including memory loss, depression, and impotence. This discovery is expected to alleviate concerns and encourage more people to take the life-saving medication, which has been proven to slash the risk of heart attacks and strokes. Meanwhile, the fight against FGM has gained momentum, with UN leaders calling for sustained commitment and investment to end the practice. An estimated 4.5 million girls, many under the age of five, are at risk of undergoing FGM in 2026 alone. The UN has reaffirmed its commitment to ending FGM and ensuring access to quality services for those subjected to the practice, which is a violation of human rights and can lead to serious, lifelong complications. In the realm of cancer screening, a new study has found that testing period blood for signs of cervical cancer could be an accurate and convenient way of screening for the disease. The current NHS test involves a nurse or doctor taking a sample of cells from the cervix, but a third of women invited for screening do not attend. The new test, which can be carried out at home, uses blood collected on a cotton strip attached to a standard sanitary pad. Preventive cholera vaccination has also resumed, with Mozambique being the first country to restart the life-saving campaigns. The global cholera vaccine supply has increased to a level sufficient to allow the resumption of preventive campaigns, which were halted in 2022 due to shortages. This development comes as a significant milestone in the fight against cholera, which affects millions worldwide. Lastly, a new global analysis from the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC) has found that up to four in ten cancer cases worldwide could be prevented. The study examines 30 preventable causes, including tobacco, alcohol, high body mass index, physical inactivity, air pollution, and ultraviolet radiation. Tobacco was found to be the leading preventable cause of cancer, globally responsible for 15% of all new cancer cases. These breakthroughs demonstrate a significant shift towards prioritizing prevention in healthcare, and their impact is expected to be far-reaching. As the medical community continues to make strides in these areas, millions of lives will be saved, and the global health landscape will be forever changed. Sources: * "Statin pills much safer than advertised, major review finds" (The Lancet) * "Over four million girls still at risk of female genital mutilation: UN leaders call for sustained commitment and investment to end FGM" (UN) * "Period blood test could offer less invasive alternative to cervical screening" (BBC) * "Preventive cholera vaccination resumes as global supply reaches critical milestone" (Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization) * "Four in ten cancer cases could be prevented globally" (World Health Organization and International Agency for Research on Cancer)